Yi-Ping Hsueh Selected Research

Yi-Ping Hsueh Research Topics

Disease

8	Autistic Disorder (Autism) 01/2023 - 05/2015
5	Infections 02/2024 - 08/2014
5	Autism Spectrum Disorder 01/2022 - 01/2014
4	Neoplasms (Cancer) 01/2022 - 07/2007
3	Nervous System Diseases (Neurological Disorders) 01/2021 - 03/2016
3	X-Linked Mental Retardation (Mental Retardation, X Linked) 01/2017 - 03/2010
2	Parkinson Disease (Parkinson's Disease) 11/2018 - 01/2006
2	Neurodevelopmental Disorders 10/2017 - 03/2016
2	Intellectual Disability (Idiocy) 01/2017 - 10/2009
2	Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia 03/2012 - 12/2011
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 05/2008 - 07/2007
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 02/2024
1	Superinfection 01/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Hyperalgesia 01/2022
1	Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease) 01/2020
1	Paralysis (Palsy) 01/2020
1	Frontotemporal Dementia (Semantic Dementia) 11/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Virus Diseases (Viral Diseases) 01/2018
1	Flavivirus Infections 01/2018
1	CDKL5 deficiency disorder 10/2017
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2017
1	Schizophrenia (Dementia Praecox) 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Learning Disabilities (Learning Disability) 12/2011
1	Dementia (Dementias) 12/2011
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2010
1	Colorectal Neoplasms (Colorectal Cancer) 09/2010
1	Lymphoma (Lymphomas) 08/2010
1	Carcinogenesis 05/2008

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2006
5	ZincIBA 01/2023 - 05/2015
5	CalciumIBA 01/2022 - 10/2009
5	Neurofibromin 1 (Neurofibromin)IBA 01/2021 - 07/2007
4	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2017 - 10/2009
4	Transcription Factors (Transcription Factor)IBA 08/2015 - 01/2006
3	Valosin Containing ProteinIBA 02/2024 - 01/2018
3	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2018
3	CytokinesIBA 01/2018 - 08/2014
2	ProteomeIBA 02/2024 - 01/2023
2	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2020
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 08/2014
2	Carrier Proteins (Binding Protein)IBA 01/2020 - 08/2010
2	Protein Kinases (Protein Kinase)IBA 01/2017 - 10/2009
2	Serine (L-Serine)FDA Link 01/2017 - 10/2009
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 08/2010 - 03/2010
1	XylansIBA 02/2024
1	Glutamic Acid (Glutamate)FDA Link 02/2024
1	Superoxide Dismutase-1IBA 02/2024
1	Interferon Type IIBA 01/2023
1	Branched-Chain Amino AcidsIBA 01/2023
1	F-actin-binding proteinsIBA 01/2023
1	Leucine (L-Leucine)FDA Link 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Cyclic ADP-Ribose (cADPR)IBA 01/2022
1	Neurofibromin 2 (Merlin)IBA 01/2021
1	ras GTPase-Activating Proteins (ras-GAP)IBA 01/2021
1	CortactinIBA 01/2020
1	SpastinIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2017
1	Ionotropic Glutamate ReceptorsIBA 01/2017
1	Toll-Like Receptor 3IBA 01/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2017
1	InflammasomesIBA 01/2017
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 09/2010
1	IgA receptor (protein B)IBA 08/2010
1	Ion Channels (Ion Channel)IBA 08/2010
1	Nucleosomes (Nucleosome)IBA 01/2006
1	SyndecansIBA 01/2006
1	Calcium Channels (Calcium Channel)IBA 01/2006

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2022
1	Therapeutics 01/2021